Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health Inc. Class A

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hims & Hers Health (HIMS – Research Report), Pharmin...

Analysts Are Bullish on These Healthcare Stocks: Hims & Hers Health (HIMS), Pharming Group (PHAR)

In a report released on January 16, Allen Lutz from Bank of America Securities maintained a Sell rating on Hims & Hers Health, with a price target ...

Bank of America Securities Remains a Sell on Hims & Hers Health (HIMS)

The least shorted stocks are Amazon and Walmart.


UAA, MARA, HIMS: The 10 Most Shorted Stocks in the Market

Stocks are on the move Thursday alongside earnings reports, analyst updates, major deals, and more.


Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

Hims & Hers Health ($HIMS) stock is down 2.8% at the time of writing, following a price target cut by a top Bank of America Securities analyst Alle...

Current Quarter	$0.04	Next Quarter	$0.14
Current Year	$0.5	Next Year	$0.58
QoQ Growth	+250.0%	YoY Growth	+16.0%
3Y EPS CAGR	+44.2%	Target Price	$42.77
Consensus	Buy	Upside	+61.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HIMS	$26.44	-2.40%	13.57M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HIMS	$26.44	-2.4%	13.57M
3
4
5
6

HIMS

HIMS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Hims & Hers Health Inc. Class A Data in Excel

Get Hims & Hers Health Inc. Class A Data in Excel